Brief: Adaptimmune Therapeutics Entered Mutual Release And Resolution Agreement With Genentech Inc & F. Hoffmann-La Roche Ltd
23/09/2024 21:47
Adaptimmune Therapeutics PLC ADAP.O :
* ADAPTIMMUNE THERAPEUTICS: ENTERED MUTUAL RELEASE AND
RESOLUTION
AGREEMENT WITH GENENTECH INC & F. HOFFMANN-LA ROCHE LTD
* ADAPTIMMUNE THERAPEUTICS: UNDER DEAL TERMS, GENENTECH TO
PAY CO
$12.5 MILLION & COLLABORATION AGREEMENT WILL BE TERMINATED
Source text for Eikon: ID:n0001558370-24-012960
Further company coverage: ADAP.O
Recent news on Adaptimmune Therapeutics
See all newsAdaptimmune Therapeutics PLC reports results for the quarter ended June 30 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 10 cents a share - Earnings Preview
Enters Settlement Agreement With MD Anderson - SEC Filing
Adaptimmune Therapeutics PLC reports results for the quarter ended March 31 - Earnings Summary
Adaptimmune Therapeutics PLC expected to post a loss of 12 cents a share - Earnings Preview